Pharmaceutical

Parkinson’s disease cases to reach 3.15 million in 7MM by 2033

Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in the seven major markets between 2023 and 2033.

Nov 21, 2024 - 06:00
Parkinson’s disease cases to reach 3.15 million in 7MM by 2033
Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in the seven major markets between 2023 and 2033.
Read the original article

Tags:

Previous Article

Veeva Commercial Summit: Increased investment in medical affairs by pharma compa...

Next Article

Pharmanovia signs license agreement for Lindis Biotech’s catumaxomab

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Former FDA official lays out how to keep patients safe from risky medical devices

STAT+: Former FDA official lays out how to keep patient...

Oct 2, 2023

AbbVie makes psychedelic play with $2bn Gilgamesh collaboration

AbbVie makes psychedelic play with $2bn Gilgamesh colla...

May 15, 2024

STAT+: Why FDA product recalls have spiked in recent years

STAT+: Why FDA product recalls have spiked in recent years

Dec 15, 2023